Browsing: Access1

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…

Semaglutide tablet (Rybelsus), the first GLP-1RA developed for oral administration, heralds a milestone for diabetes management in the 15 years…

Cardio-renal protection with SGLT2i in T2DM patients Date: 7 Oct 2021 (Thursday) Time: 1-2pm (GMT +8) Hosted by: Merck Chairperson:…

Hot on the heels of sotrovimab, the Health Science’s Authority  (HSA) has granted pandemic special access route (PSAR) interim authorization…

It is estimated that 15% to 20% of women with newly diagnosed breast cancer have tumours that over-express human epidermal…

In May 2021, the Health Sciences Authority (HSA) approved the use of Romosozumab (Evenity), a novel biologic, for the treatment…

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…

On 13 and 17 October 2020, COPDAS organised a webinar on improving quality of life in symptomatic COPD patients, as part of…

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…

As the COVID-19 pandemic enters into its 18-month mark, the global race for novel therapeutics blazes on, with international guidelines…